Businessman tries his luck at building pot brand

by Gene Johnson

(AP)—The plans of a former Microsoft manager to create the "Starbucks of Pot" are worrying other activists who pushed for the legalization of marijuana in Washington state.

They say Jamen Shively's ambitions don't merely raise questions about whether big corporations will come to dominate the legal pot industry, but also about whether his profit-driven approach might cause a backlash that could slow the marijuana reform movement across the country.

Shively is trying to raise $10 million from investors and eventually wants to build his company, Diego Pellicer (pay-EE'-sehr), into an international pot powerhouse.

But the states aren't licensing marijuana stores yet. say the way Shively is going about making deals with dispensaries could risk federal prosecution.

5 /5 (1 vote)
add to favorites email to friend print save as pdf

Related Stories

Court: California cities can ban pot shops

May 06, 2013

(AP)—The California Supreme Court ruled Monday that cities and counties can ban medical marijuana dispensaries, a ruling likely to further diminish the state's once-extravagant network of storefront pot shops and fuel efforts ...

LA council votes to repeal pot dispensary ban

Oct 03, 2012

(AP)—The Los Angeles City Council reversed course Tuesday and repealed a ban on pot shops that it passed just two months ago to shutter hundreds of medical marijuana storefronts.

Recommended for you

Why aren't there any human doctors in Star Wars?

19 hours ago

Though set "a long time ago in a galaxy far, far away," it isn't hard to see in the Star Wars films a vision of our own not so distant future. But Anthony Jones, a physician with a long background in health ...

Cambodia bans 'virgin surgery' adverts

Jan 29, 2015

The Cambodian government has ordered a hospital to stop advertising so-called virginity restoration procedures, saying it harms the "morality" of society.

What's happening with your donated specimen?

Jan 28, 2015

When donating blood, plasma, human tissue or any other bodily sample for medical research, most people might not think about how it's being used. But if you were told, would you care?

Amgen tops Street 4Q forecasts

Jan 27, 2015

Amgen Inc. cruised to a 27 percent jump in fourth-quarter profit and beat Wall Street expectations, due to higher sales of nearly all its medicines, tight cost controls and a tax benefit.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.